ExLibris header image
SFX Logo
Title: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Perry, Jennifer yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "Abstract 3004: Comparison of somatic alterations in the genome and transcriptome of 1,705 pediatric leukemia and solid tumors: a report from the Children’s Oncology Group (COG) - NCI TARGET Project." Cancer research. 3004-3004. Link to SFX for this item
2. Lorenz, S. "Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations." Oncotarget 7.5 (2015): 5273-5288. Link to Full Text for this item Link to SFX for this item
3. Koehler, K. "TP53 mutational status is predictive of pazopanib response in advanced sarcomas." Annals of oncology 27.3 (2015): 539-543. Link to SFX for this item
4. Mirabello, L. "A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma." Cancer discovery 5.9 (2015): 920-931. Link to SFX for this item
5. Papachristou, Dionysios J J. "Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis." Human pathology 37.7 (2006): 890-898. Link to SFX for this item
6. Bill, Kate Lynn J L. "SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma." Clinical cancer research 22.5 (2016): 1150-1160. Link to SFX for this item
7. Masui, F. "Chondroblastoma: a study of 11 cases." European journal of surgical oncology 28.8 (2002): 869-874. Link to SFX for this item
8. Armstrong, A. "TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder." Modern pathology 22.1 (2009): 113-118. Link to Full Text for this item Link to SFX for this item
9. D'Angelo, E. "Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system." Human Pathology 40.11 (2009): 1571-1585. Link to SFX for this item
10. Caronia, D. "Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients." The Pharmacogenomics Journal 9.5 (2009): 347-353. Link to Full Text for this item Link to SFX for this item
11. Murakami, K. "Nerve injury induces the expression of EXT2, a glycosyltransferase required for heparan sulfate synthesis." Neuroscience 141.4 (2006): 1961-9. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced